World Congress Leadership Summit On Optimizing Observation Patient Management To Convene 23-24 April 2012, Chicago
As recent evidence supports the effectiveness of patient observation units, World Congress is pleased to present the Leadership Summit on Optimizing Observation Patient Management, April 23-24 in Chicago. The forum will showcase how leading hospitals and healthcare systems operate and effectively utilize their observation units. Patient observation units are growing in popularity in many hospitals, serving as a "middle ground" between busy emergency department and inpatient beds. They can serve as a cost-effective alternative for patients who may not need to be admitted for inpatient treatment, but should not be released from the emergency department. Patients send to observation units within hospitals often suffer from chest pain, asthma, dehydration and seizures. Summit topics include: Critical Consideration to Ensure the Creation of a Successful Center Operational Effectiveness: How to Optimize the Center Once it is Created The Observation Unit vs.
NIH-supported scientists will be presenting their latest research findings at the 2012 Midwinter Meeting of the Association for Research in Otolaryngology (ARO) February 25-29, 2012 at The Manchester Grand Hyatt Hotel, San Diego, California, USA. Research topics to be presented by NIDCD-funded scientists will include: Bilateral / Binaural: Can the Ability to Localize Sounds Be Regained After Bilateral Cochlear Implantation? Ruth Litovsky, Ph.D., University of Wisconsin-Madison Bilateral cochlear implants - one implant for each ear - are becoming more common as a treatment for children who are deaf or hard-of-hearing. Many children with cochlear implants attain spoken language skills that are comparable to their hearing peers, but even with two implants children often appear to perform significantly worse on tasks that involve hearing in complex listening environments (a busy classroom, for example) where they need to distinguish a teacher's or classmate's voice from competing background noise.
Because rare diseases affect only a tiny group of people, pursuing the development of treatments has traditionally not been attractive for pharma companies. However, there are currently lucrative benefits in place set by the regulatory bodies that reward R&D efforts for orphan drugs by ensuring less intense competition, faster and less expensive development, protocol assistance and lower marketing expenses. In order to discuss major concerns, the newest solutions and challenges resulting from these tendencies, Fleming Europe has organized its 2nd Annual Orphan Drug Congress 2012. On 7 - 8 June the top-level pharmaceutical experts in orphan drug development, regulatory affairs & pricing will gather in sunny Barcelona to discuss this year's critical issues. Segolene Ayme, Director of Research from INSERM will open the conference with the International Rare Disease Research Initiative.
The current situation in the pharma industry is characterized by the increased counterfeiting and non-compliance practices which represent major obstacles to providing the best healthcare for patients. At the same time, pharma packagers have to deal with the newest waves of regulations, process optimization hurdles as well as patient adherence challenges. The 2nd Annual Pharma Packaging & Labeling Compliance Conference follows up on last year's successful event. It is scheduled on 8 - 9 March 2012 and takes place in the Eternal city of Rome, Italy. Confirmed venue is Parco dei Principi Grand Hotel & Spa, situated in the exclusive Parioli district. This conference brings detailed insights into the newest standards, anti-counterfeiting techniques and 2D barcoding integrity issues. Top-level speakers are also ready to provide answers and solutions about good designs and safer medicines, child resistant packaging, country specific ways of serialization and new QRD Template & Information based labeling.
Rise In Heart Disease Prevalence In The Gulf States Linked To Rapid Urbanisation As Well As Cultural Habits
While the rapid improvement in socio-economic conditions is thought responsible for the high rates of cardiovascular disease in the Gulf states, deep-rooted cultural factors also play a part. "We're sitting on a time bomb, " says Professor Hani Najm, Vice-President of the Saudi Heart Association, whose annual conference begins Friday 27 January. "We will see a lot of heart disease over the next 15 to 20 years. Already, services are saturated. We now have to direct our resources to the primary prevention of risk factors throughout the entire Middle East." World Health Organization figures show that up to 60% of males in Arab countries and up to 70% of females are overweight and obese. Prevalence rates of diabetes and hypertension are around 25%, while inactivity rates among the over-20s are even higher.